BioXcel Therapeutics Announces $1.25M Additional Loans From Oaktree With 20% Upfront Fee; Minimum Liquidity Covenant Cut To $250K From $3M, Must Reach Repayment Or Capital Deal By August 31

Benzinga Newsdesk www.benzinga.com Positive 90.4%

Neg 0% Neu 0% Pos 90.4%

Comments

No comments yet. Be the first!